About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 879491, 5 pages
http://dx.doi.org/10.1155/2013/879491
Clinical Study

Infliximab Extends the Duration until the First Surgery in Patients with Crohn’s Disease

1Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University, 2-1 Midorigaoka-higashi, Asahikawa, Hokkaido 078-8510, Japan
2Division of Gastroenterological and General Surgery, Department of Surgery, Asahikawa Medical University, 2-1 Midorigaoka-higashi, Asahikawa, Hokkaido 078-8510, Japan
3Department of Gastroenterology, Sapporo Higashi Tokushukai Hospital, 3-1 North 33-jou East 14-chome East Ward, Sapporo, Hokkaido 065-0033, Japan

Received 16 July 2013; Revised 19 October 2013; Accepted 20 October 2013

Academic Editor: Hidekazu Kuramochi

Copyright © 2013 Aki Sakatani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Aki Sakatani, Mikihiro Fujiya, Takahiro Ito, et al., “Infliximab Extends the Duration until the First Surgery in Patients with Crohn’s Disease,” BioMed Research International, vol. 2013, Article ID 879491, 5 pages, 2013. doi:10.1155/2013/879491